The digital pathology market share is expected to witness significant growth in the coming years. With advancements in technology and increasing adoption of digital solutions in the healthcare industry, the demand for digital pathology systems is on the rise.

One of the key factors driving the market share is the need for efficient and accurate diagnosis. Digital pathology allows pathologists to view high-resolution images of tissue samples on a computer screen, enabling them to make more precise diagnoses. This eliminates the need for physical slides and enables remote access to images, facilitating collaboration among pathologists and improving patient care.

Moreover, digital pathology offers several advantages over traditional methods, such as faster turnaround time, reduced risk of sample loss or damage, and improved workflow efficiency. These benefits are attracting healthcare providers to invest in digital pathology solutions, thereby contributing to the market share growth.

The Digital Pathology Market size was estimated at USD 1006 million annually by 2022, and is expected to reach USD 1782 million by 2030 and improve to a CAGR of 7.4% over the estimated period 2023-2030.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1763

KEY MARKET SEGMENTATION:

By Product

  • Scanners
    • Brightfield
    • Other Scanners
  • Software
  • Integrated Software
  • Standalone Software
  • Information Management Software
  • Image Analysis Software
  • Storage Systems

By Type

  • Human Pathology
  • Veterinary Pathology

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Training & Education

By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic & Research Institutes

Some of the major key players are as follows: 3DHISTECH Ltd., F. Hoffmann-La Roche Ltd., Hamamatsu Photonics, Inc., Huron Technologies International, Inc., Inspirata, Inc., Koninklijke Philips N.V., Leica Biosystems (Danaher), Mikroscan Technologies, Olympus Corporation, Visiopharm A/S, and other players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com